Evidence map›Paper›PMID 41239322›Full record

ArticleBMC cancer2025

Facilitator and barrier perspectives on learning and implementing high-resolution anoscopy in Abuja, Nigeria: a qualitative study.

Megan E Mansfield, Connor R Volpi, Chama John, Ruxton Adebiyi, Andrew Mitchell, Jumoke A Aigoro, Yerima Jibrin Bawa, Kazeem E Kolawole, Uchenna Ononaku, Paul Jibrin and 10 more

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Megan E Mansfield *Institute of Human Virology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Connor R Volpi *Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Chama JohnInstitute of Human Virology Nigeria, Abuja, Nigeria.
Ruxton AdebiyiInstitute of Human Virology Nigeria, Abuja, Nigeria.
Andrew MitchellInstitute of Human Virology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Jumoke A AigoroInstitute of Human Virology Nigeria, Abuja, Nigeria.
Yerima Jibrin BawaInstitute of Human Virology Nigeria, Abuja, Nigeria.
Kazeem E KolawoleInstitute of Human Virology Nigeria, Abuja, Nigeria.
Uchenna OnonakuInstitute of Human Virology Nigeria, Abuja, Nigeria.
Paul JibrinNational Hospital, Abuja, Nigeria.
Oluwole OlaomiNational Hospital, Abuja, Nigeria.
Francis AgboNational Agency for the Control of AIDS, Abuja, Nigeria.
Abayomi AkaInternational Center for Advocacy on Rights to Health, Abuja, Nigeria.
Søren M BentzenUniversity of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Stephen E GoldstoneIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Patrick DakumInstitute of Human Virology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Joel M PalefskyUniversity of California, San Francisco, San Francisco, CA, USA.
Cheryl KnottUniversity of Maryland, College Park, College Park, MD, USA.
Sylvia Adebajo *Institute of Human Virology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Rebecca G Nowak *Institute of Human Virology, University of Maryland, School of Medicine, Baltimore, MD, USA. rnowak@ihv.umaryland.edu.

Funding

INSTITUTIONAL RESEARCH CANCER EPIDEMIOLOGY FELLOWSHIPT32CA009314 · NCI · JOHNS HOPKINS UNIVERSITY · PI Corinne E. Joshu, Meghan Bridgid Moran · 1985 to 2026
$11.2M
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)U01CA275053 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Sylvia Adebajo, Rebecca G. Nowak · 2022 to 2026
$4.1M
Maryland Department of Health CH-649-CRFNCI NIH HHS T32 CA009314NCI NIH HHS U01 CA275053NCI NIH HHS U01CA275053U.S. President's Emergency Plan for AIDS Relief NU2GGH002099
6 · The paper itself

Abstract

backgroundEarly detection and treatment of anal precancer via high resolution anoscopy (HRA) is paramount to prevent anal cancer, particularly for populations at heightened risk like sexual minority men (SMM) living with HIV. Successful training and sustainability of cancer screening requires attention to local contexts, best captured by qualitative research. Using the Consolidated Framework for Implementation Research (CFIR), this study investigated factors that challenged or fostered learning and implementing HRA across a variety of stakeholder groups in Abuja, Nigeria.

methodsUsing in-depth qualitative methodology, nineteen semi-structured interviews were conducted in September 2023 with stakeholders - patients who underwent HRA, HRA providers, and health system representatives in Nigeria. Thematic analysis, guided by CFIR, was employed to identify key themes related to the barriers and facilitators to practicing HRA as guided by the International Anal Neoplasia Society.

resultsEight themes were identified across three domains. Barriers included low knowledge and understanding of HRA, with participants explicitly noting the need for more research in low resource settings to garner local acceptance. Participants were concerned about financial costs for the clinic and the patients. Facilitators included organizational buy-in, SMM social networks, and a safe clinic environment to support HRA engagement. Facilitators important for sustainability included acceptance of the research evidence for HRA and recognition of the health benefits. Overall, participants from all stakeholder groups welcomed HRA as a new evidence-based intervention as part of HIV care services.

conclusionsOur study highlighted the need for localized research, cultural sensitivity, and resource allocation to improve the adoption of HRA in a Nigerian HIV care setting. Organizational buy-in, community engagement, and safe healthcare environments facilitated trust and patient engagement and would promote long term sustainability. Overall, the study provided perspectives from various stakeholders that strengthen clinical proficiency and sustainability of anal cancer screening in Nigeria.

Indexed as

Anus NeoplasmsEarly Detection of CancerAdultFemaleHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansMaleMiddle AgedNigeriaQualitative ResearchSexual and Gender MinoritiesAfricaAnal cancer preventionImplementation science

Identifiers

PMID41239322
PMCPMC12619308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.